Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Zeiser, R."" wg kryterium: Autor


Wyświetlanie 1-16 z 16
Tytuł:
Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease.
Autorzy:
Bonig H; Faculty of Medicine, Institute for Transfusion Medicine and Immunohematology, Goethe University, Frankfurt, Germany.; German Red Cross Blood Service BaWüHe, Institute Frankfurt, Frankfurt, Germany.; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.
Verbeek M; School of Medicine, Technical University Munich, Klinikum Rechts Der Isar, Clinic and Policlinic for Internal Medicine III, Munich, Germany.
Herhaus P; School of Medicine, Technical University Munich, Klinikum Rechts Der Isar, Clinic and Policlinic for Internal Medicine III, Munich, Germany.
Braitssch K; School of Medicine, Technical University Munich, Klinikum Rechts Der Isar, Clinic and Policlinic for Internal Medicine III, Munich, Germany.
Beutel G; Hannover Medical School, Department of Hematology, and Stem Cell Transplantation, HemostasisHannover, Oncology, Germany.
Schmid C; Augsburg University Hospital and Medical Faculty, Augsburg, Germany.
Müller N; Universitätsklinikum Mannheim, Mannheim, Germany.
Bug G; Department of Medicine 2, University Hospital, Goethe University, Frankfurt, Germany.
Döring M; Universitätsklinik Für Kinder Und Jugendmedizin, Tübingen, Germany.
von Stackelberg A; Charité, Universitätsmedizin Berlin, Berlin, Germany.
Tischer J; Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
Ayuk F; Klinik Für Stammzelltransplantation, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Wulf G; Hämatologie Und Medizinische Onkologie, Universitätsmedizin Göttingen, Göttingen, Germany.
Holtick U; Universitätsklinikum Köln, Cologne, Germany.
Pfeffermann LM; German Red Cross Blood Service BaWüHe, Institute Frankfurt, Frankfurt, Germany.
Jahrsdörfer B; Institute for Clinical Transfusion Medicine and Immunogenetics, University of Ulm, Ulm, Germany.
Schrezenmeier H; Institute for Clinical Transfusion Medicine and Immunogenetics, University of Ulm, Ulm, Germany.
Kuci S; Department of Pediatrics, Division for Stem Cell Transplantation and Immunology, Goethe University, Frankfurt, Germany.
Kuci Z; Department of Pediatrics, Division for Stem Cell Transplantation and Immunology, Goethe University, Frankfurt, Germany.
Zens A; Medac Gesellschaft Für Klinische Spezialpräparate mbH, Wedel, Germany.
Tribanek M; Medac Gesellschaft Für Klinische Spezialpräparate mbH, Wedel, Germany.
Zeiser R; Department Innere Medizin, Klinik Für Innere Medizin I, Universitätsklinikum Freiburg, Freiburg, Germany.
Huenecke S; Department of Pediatrics, Division of Stem Cell Transplantation and Immunology, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
Bader P; Department of Pediatrics, Division of Stem Cell Transplantation and Immunology, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2023 Nov 21; Vol. 21 (1), pp. 837. Date of Electronic Publication: 2023 Nov 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Mesenchymal Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/adverse effects
Graft vs Host Disease*/drug therapy
Mesenchymal Stem Cells*
Child ; Adult ; Humans ; Retrospective Studies ; Acute Disease
Czasopismo naukowe
Tytuł:
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey.
Autorzy:
Zeiser R; Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, Freiburg, Germany.
Burchert A; Department of Hematology, Oncology and Immunology, Philipps University Marburg, and University Medical Center Giessen and Marburg, Marburg, Germany.
Lengerke C; Division of Hematology, University Hospital of Basel, Basel, Switzerland.
Verbeek M; III Department of Internal Medicine, Technical University of Munich, Munich, Germany.
Maas-Bauer K; Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, Freiburg, Germany.
Metzelder SK; Department of Hematology, Oncology and Immunology, Philipps University Marburg, and University Medical Center Giessen and Marburg, Marburg, Germany.
Spoerl S; III Department of Internal Medicine, Technical University of Munich, Munich, Germany.
Ditschkowski M; Department of Bone Marrow Transplantation, West German Cancer Center, University Hospital Essen, Essen, Germany.
Ecsedi M; Division of Hematology, University Hospital of Basel, Basel, Switzerland.
Sockel K; Department of Hematology and Oncology, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Germany.
Ayuk F; Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Ajib S; Department of Internal Medicine II, University Hospital, Frankfurt/Main, Germany.
de Fontbrune FS; Hematology Stem cell transplant Unit, Saint Louis Hospital, APHP, Paris, France.
Na IK; Department of Stem Cell Transplantation, Charité University Medicine Berlin, Berlin, Germany.
Penter L; Department of Stem Cell Transplantation, Charité University Medicine Berlin, Berlin, Germany.
Holtick U; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.
Wolf D; Medical Clinic III, Oncology, Hematology and Rheumatology, University Hospital Bonn (UKB), Bonn, Germany.
Schuler E; Department of Hematology, Oncology and Clinical Immunology, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
Meyer E; Department of Bone Marrow Transplantation, Stanford University Medical School, Stanford, CA, USA.
Apostolova P; Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, Freiburg, Germany.
Bertz H; Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, Freiburg, Germany.
Marks R; Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, Freiburg, Germany.
Lübbert M; Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, Freiburg, Germany.
Wäsch R; Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, Freiburg, Germany.
Scheid C; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.
Stölzel F; Department of Hematology and Oncology, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Germany.
Ordemann R; Department of Hematology and Oncology, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Germany.
Bug G; Department of Internal Medicine II, University Hospital, Frankfurt/Main, Germany.
Kobbe G; Department of Hematology, Oncology and Clinical Immunology, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
Negrin R; Department of Bone Marrow Transplantation, Stanford University Medical School, Stanford, CA, USA.
Brune M; Department of Internal Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.
Spyridonidis A; Department of Bone Marrow Transplantation, Patras University Medical School, Patras, Greece.
Schmitt-Gräff A; Department of Pathology, Freiburg University Medical Center, Freiburg, Germany.
van der Velden W; Radboud University Medical Centre, Nijmegen, The Netherlands.
Huls G; Radboud University Medical Centre, Nijmegen, The Netherlands.
Mielke S; Department of Hematology and Oncology, University Medical Centre Würzburg, Würzburg, Germany.
Grigoleit GU; Department of Hematology and Oncology, University Medical Centre Würzburg, Würzburg, Germany.
Kuball J; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
Flynn R; Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN, USA.
Ihorst G; Clinical Trials Unit, Department of Hematology, Freiburg University Medical Center, Freiburg, Germany.
Du J; Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN, USA.
Blazar BR; Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN, USA.
Arnold R; Department of Stem Cell Transplantation, Charité University Medicine Berlin, Berlin, Germany.
Kröger N; Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Passweg J; Division of Hematology, University Hospital of Basel, Basel, Switzerland.
Halter J; Division of Hematology, University Hospital of Basel, Basel, Switzerland.
Socié G; Hematology Stem cell transplant Unit, Saint Louis Hospital, APHP, Paris, France.
Beelen D; Department of Bone Marrow Transplantation, West German Cancer Center, University Hospital Essen, Essen, Germany.
Peschel C; III Department of Internal Medicine, Technical University of Munich, Munich, Germany.
Neubauer A; Department of Hematology, Oncology and Immunology, Philipps University Marburg, and University Medical Center Giessen and Marburg, Marburg, Germany.
Finke J; Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, Freiburg, Germany.
Duyster J; Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, Freiburg, Germany.
von Bubnoff N; Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, Freiburg, Germany.
Pokaż więcej
Źródło:
Leukemia [Leukemia] 2015 Oct; Vol. 29 (10), pp. 2062-8. Date of Electronic Publication: 2015 Jul 31.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Salvage Therapy*
Adrenal Cortex Hormones/*pharmacology
Drug Resistance, Neoplasm/*drug effects
Graft vs Host Disease/*drug therapy
Hematologic Neoplasms/*complications
Hematopoietic Stem Cell Transplantation/*adverse effects
Pyrazoles/*therapeutic use
Adult ; Aged ; Animals ; Disease Models, Animal ; Female ; Follow-Up Studies ; Graft vs Host Disease/etiology ; Graft vs Host Disease/mortality ; Hematologic Neoplasms/therapy ; Humans ; Janus Kinases/antagonists & inhibitors ; Male ; Mice ; Middle Aged ; Neoplasm Staging ; Nitriles ; Prognosis ; Pyrimidines ; Recurrence ; Retrospective Studies ; Survival Rate ; Transplantation, Homologous ; Young Adult
Czasopismo naukowe
Tytuł:
Insights into the pathogenesis of GvHD: what mice can teach us about man.
Autorzy:
Hülsdünker J; Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, Albert Ludwigs University Freiburg, Freiburg, Germany; Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, Freiburg, Germany; Faculty of Biology, University of Freiburg, Freiburg, Germany.
Zeiser R
Pokaż więcej
Źródło:
Tissue antigens [Tissue Antigens] 2015 Jan; Vol. 85 (1), pp. 2-9. Date of Electronic Publication: 2014 Dec 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Graft vs Leukemia Effect*
Hematopoietic Stem Cell Transplantation*
Graft vs Host Disease/*pathology
Graft vs Host Disease/*therapy
Leukemia/*therapy
T-Lymphocytes, Regulatory/*immunology
Adoptive Transfer ; Animals ; Antineoplastic Agents/pharmacology ; Disease Models, Animal ; Graft vs Host Disease/genetics ; Graft vs Host Disease/immunology ; Humans ; Hydroxamic Acids/pharmacology ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology ; Leukemia/genetics ; Leukemia/immunology ; Leukemia/pathology ; Mice ; Mice, Knockout ; Receptors, CCR5/genetics ; Receptors, CCR5/immunology ; T-Lymphocytes, Regulatory/cytology ; T-Lymphocytes, Regulatory/transplantation ; Transplantation, Homologous ; Vorinostat
Czasopismo naukowe
Tytuł:
Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage.
Autorzy:
Schwab L; 1] Department of Hematology and Oncology, University Medical Center, Freiburg, Germany. [2].
Goroncy L; 1] Department of Hematology and Oncology, University Medical Center, Freiburg, Germany. [2] Faculty of Biology, Albert-Ludwigs-University, Freiburg, Germany. [3].
Palaniyandi S; 1] Division of Hematology and Oncology, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA. [2] Division of Bone Marrow Transplantation, University of Utah School of Medicine, Huntsman Cancer Institute, Salt Lake City, Utah, USA. [3].
Gautam S; 1] Faculty of Biology, Albert-Ludwigs-University, Freiburg, Germany. [2] Department of Medical Microbiology and Hygiene, University Medical Center, Freiburg, Germany. [3] Spemann Graduate School of Biology and Medicine, Albert-Ludwigs-University Freiburg, Germany.
Triantafyllopoulou A; Center of Chronic Immunodeficiency, Albert-Ludwigs-University Freiburg, Germany.
Mocsai A; Department of Physiology, Semmelweis University School of Medicine, Budapest, Hungary.
Reichardt W; Department of Radiology Medical Physics, University Medical Center, Freiburg, Germany.
Karlsson FJ; Division of Hematology and Oncology, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.
Radhakrishnan SV; 1] Division of Hematology and Oncology, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA. [2] Division of Bone Marrow Transplantation, University of Utah School of Medicine, Huntsman Cancer Institute, Salt Lake City, Utah, USA.
Hanke K; 1] Department of Hematology and Oncology, University Medical Center, Freiburg, Germany. [2] Faculty of Biology, Albert-Ludwigs-University, Freiburg, Germany.
Schmitt-Graeff A; Department of Pathology, University Medical Center, Albert-Ludwigs-University, Freiburg, Germany.
Freudenberg M; 1] Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. [2] Centre for Biological Signaling Studies BIOSS, Albert-Ludwigs-University Freiburg, Germany.
von Loewenich FD; Department of Medical Microbiology and Hygiene, University Medical Center, Freiburg, Germany.
Wolf P; Department of Urology, University Medical Center, Freiburg, Germany.
Leonhardt F; 1] Department of Hematology and Oncology, University Medical Center, Freiburg, Germany. [2] Faculty of Biology, Albert-Ludwigs-University, Freiburg, Germany.
Baxan N; Department of Radiology Medical Physics, University Medical Center, Freiburg, Germany.
Pfeifer D; Department of Hematology and Oncology, University Medical Center, Freiburg, Germany.
Schmah O; Department of Hematology and Oncology, University Medical Center, Freiburg, Germany.
Schönle A; Department of Hematology and Oncology, University Medical Center, Freiburg, Germany.
Martin SF; Allergy Research Group, Department of Dermatology, University Medical Center, University Freiburg, Germany.
Mertelsmann R; Department of Hematology and Oncology, University Medical Center, Freiburg, Germany.
Duyster J; Department of Hematology and Oncology, University Medical Center, Freiburg, Germany.
Finke J; Department of Hematology and Oncology, University Medical Center, Freiburg, Germany.
Prinz M; 1] Spemann Graduate School of Biology and Medicine, Albert-Ludwigs-University Freiburg, Germany. [2] Department of Neuropathology, University Medical Center, Freiburg, Germany.
Henneke P; 1] Center of Chronic Immunodeficiency, Albert-Ludwigs-University Freiburg, Germany. [2] Center for Pediatrics and Adolescent Medicine, University Medical Center, Freiburg, Germany.
Häcker H; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Hildebrandt GC; 1] Division of Hematology and Oncology, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA. [2] Division of Bone Marrow Transplantation, University of Utah School of Medicine, Huntsman Cancer Institute, Salt Lake City, Utah, USA. [3].
Häcker G; 1] Department of Medical Microbiology and Hygiene, University Medical Center, Freiburg, Germany. [2] Spemann Graduate School of Biology and Medicine, Albert-Ludwigs-University Freiburg, Germany. [3].
Zeiser R; 1] Department of Hematology and Oncology, University Medical Center, Freiburg, Germany. [2] Spemann Graduate School of Biology and Medicine, Albert-Ludwigs-University Freiburg, Germany. [3] Centre for Biological Signaling Studies BIOSS, Albert-Ludwigs-University Freiburg, Germany. [4].
Pokaż więcej
Źródło:
Nature medicine [Nat Med] 2014 Jun; Vol. 20 (6), pp. 648-54. Date of Electronic Publication: 2014 May 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Graft vs Host Disease/*immunology
Hematopoietic Stem Cell Transplantation/*adverse effects
Ileum/*immunology
Microbiota/*immunology
Neutrophils/*immunology
Animals ; Busulfan ; Cyclophosphamide ; Flow Cytometry ; Freund's Adjuvant ; Graft vs Host Disease/physiopathology ; Histological Techniques ; Ileum/microbiology ; Immunohistochemistry ; Kaplan-Meier Estimate ; Luciferases ; Magnetic Resonance Imaging ; Membrane Glycoproteins/genetics ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Microarray Analysis ; NADPH Oxidase 2 ; NADPH Oxidases/genetics ; Peroxidase ; Reactive Oxygen Species/metabolism
Czasopismo naukowe
Tytuł:
A diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine model.
Autorzy:
Bäuerlein CA; Department of Medicine II, Würzburg University Clinics, Zinklesweg 10, Würzburg, D-97078, Germany.
Riedel SS
Baker J
Brede C
Garrote AL
Chopra M
Ritz M
Beilhack GF
Schulz S
Zeiser R
Schlegel PG
Einsele H
Negrin RS
Beilhack A
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2013 May 21; Vol. 11, pp. 134. Date of Electronic Publication: 2013 May 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Disease Models, Animal*
Graft vs Host Disease/*diagnosis
Graft vs Host Disease/*surgery
Hematopoietic Stem Cell Transplantation/*methods
T-Lymphocyte Subsets/*transplantation
Acute Disease ; Animals ; Blood Group Incompatibility/immunology ; Female ; Forecasting ; Graft vs Host Disease/immunology ; HLA Antigens/immunology ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; T-Lymphocyte Subsets/immunology ; Time Factors ; Transplantation, Homologous ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Ectonucleotidases in solid organ and allogeneic hematopoietic cell transplantation.
Autorzy:
Chernogorova P; Department of Hematology and Oncology, Freiburg University Medical Center, Albert-Ludwigs-University, 79106 Freiburg, Germany. />Zeiser R
Pokaż więcej
Źródło:
Journal of biomedicine & biotechnology [J Biomed Biotechnol] 2012; Vol. 2012, pp. 208204. Date of Electronic Publication: 2012 Oct 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Organ Transplantation*
5'-Nucleotidase/*metabolism
Animals ; Graft Rejection/enzymology ; Graft Rejection/physiopathology ; Graft vs Host Disease/enzymology ; Graft vs Host Disease/physiopathology ; Humans ; Transplantation, Homologous
Czasopismo naukowe
Tytuł:
Allogeneic hematopoietic cell transplantation for t-AML following liver transplantation from the same haploidentical donor.
Autorzy:
Zeiser R
Zerweck A
Bertz H
Finke J
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2009 Apr; Vol. 43 (7), pp. 589-90. Date of Electronic Publication: 2008 Nov 03.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Liver Transplantation*
Leukemia, Myeloid, Acute/*therapy
Aged ; Fatal Outcome ; Hepatitis C/complications ; Humans ; Liver Cirrhosis/therapy ; Liver Cirrhosis/virology ; Male ; Tissue Donors
Raport
Tytuł:
Fatal varicella zoster virus encephalitis in two patients following allogeneic hematopoietic stem cell transplantation.
Autorzy:
Hackanson B; Department of Hematology/Oncology, Freiburg University Medical Center, Freiburg, Germany. />Zeiser R
Bley TA
Pantazis G
Huzly D
Bertz H
Finke J
Pokaż więcej
Źródło:
Clinical transplantation [Clin Transplant] 2005 Aug; Vol. 19 (4), pp. 566-70.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Encephalitis, Varicella Zoster/*etiology
Acyclovir/therapeutic use ; Aged ; Encephalitis, Varicella Zoster/drug therapy ; Fatal Outcome ; Female ; Herpes Zoster/etiology ; Humans ; Immunocompromised Host ; Immunoglobulins/therapeutic use ; Male ; Middle Aged
Czasopismo naukowe
Tytuł:
Human hematopoietic cell transplantation results in generation of donor-derived epithelial cells.
Autorzy:
Metaxas Y
Zeiser R
Schmitt-Graeff A
Waterhouse M
Faber P
Follo M
Bertz H
Finke J
Spyridonidis A
Pokaż więcej
Źródło:
Leukemia [Leukemia] 2005 Jul; Vol. 19 (7), pp. 1287-9.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Transplantation Chimera*
Epithelial Cells/*cytology
Epithelial Cells/*immunology
Female ; Humans ; Male ; Mouth Mucosa/cytology
Raport
Tytuł:
Capillary electrophoresis for chimerism monitoring by PCR amplification of microsatellite markers after allogeneic hematopoietic cell transplantation.
Autorzy:
Spyridonidis A; Department of Hematology and Oncology, Albert Ludwigs University Medical Center, Freiburg, Germany.
Zeiser R
Wäsch R
Bertz H
Finke J
Pokaż więcej
Źródło:
Clinical transplantation [Clin Transplant] 2005 Jun; Vol. 19 (3), pp. 350-6.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Chimerism*
Hematopoietic Stem Cell Transplantation*
Electrophoresis, Capillary/*methods
Microsatellite Repeats/*genetics
Hematologic Diseases/therapy ; Humans ; In Vitro Techniques ; Lymphatic Diseases/therapy ; Polymerase Chain Reaction ; Reproducibility of Results ; Sensitivity and Specificity ; Transplantation, Homologous
Czasopismo naukowe
Tytuł:
Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation.
Autorzy:
Zeiser R; Department of Hematology and Oncology, Freiburg University Medical Center, Albert-Ludwigs University, Freiburg, Germany.
Spyridonidis A
Wäsch R
Ihorst G
Grüllich C
Bertz H
Finke J
Pokaż więcej
Źródło:
Leukemia [Leukemia] 2005 May; Vol. 19 (5), pp. 814-21.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hematopoietic Stem Cell Transplantation/*adverse effects
Immunotherapy, Adoptive/*methods
Leukemia, Myeloid/*therapy
Lymphocyte Transfusion/*methods
Myelodysplastic Syndromes/*therapy
Transplantation Chimera/*immunology
Cell Lineage/genetics ; Follow-Up Studies ; Hematopoietic Stem Cell Transplantation/methods ; Humans ; Recurrence ; Remission Induction ; Sensitivity and Specificity ; Transplantation Chimera/genetics ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome.
Autorzy:
Zeiser R; Department of Hematology/Oncology, Freiburg University Medical Center, Hugstetterstrasse 55, 79106 Freiburg, Germany.
Deschler B
Bertz H
Finke J
Engelhardt M
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2004 Dec; Vol. 34 (12), pp. 1057-65.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation/*methods
Multiple Myeloma/*pathology
Multiple Myeloma/*secondary
Multiple Myeloma/*therapy
Adult ; Bone Marrow/pathology ; Female ; Hematopoietic Stem Cell Transplantation/mortality ; Humans ; Lymphocyte Transfusion ; Male ; Middle Aged ; Multiple Myeloma/mortality ; Neoplasm Staging/methods ; Prognosis ; Prospective Studies ; Recurrence ; Transplantation, Autologous ; Transplantation, Homologous
Czasopismo naukowe
Tytuł:
Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectives.
Autorzy:
Zeiser R; Department of Hematology and Oncology, Albert Ludwigs University Medical Center Freiburg, Freiburg, Germany.
Bertz H
Spyridonidis A
Houet L
Finke J
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2004 Dec; Vol. 34 (11), pp. 923-8.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Graft vs Leukemia Effect*
Hematopoietic Stem Cell Transplantation*/mortality
Hematopoietic Stem Cell Transplantation*/trends
Lymphocyte Transfusion*/trends
Multiple Myeloma/*therapy
Neoplasm Recurrence, Local/*therapy
Female ; Graft vs Host Disease/prevention & control ; Humans ; Male
Czasopismo naukowe
Tytuł:
Late cytomegalovirus polyradiculopathy following haploidentical CD34+-selected hematopoietic stem cell transplantation.
Autorzy:
Zeiser R; Department of Hematology/Oncology, Medical Center, University of Freiburg, Hugstetterstrasse 55, Freiburg 79106, Germany. zeiser@mm11.ukl.uni-freiburg.de
Grüllich C
Bertz H
Pantazis G
Hufert FT
Bley TA
Finke J
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2004 Jan; Vol. 33 (2), pp. 243-5.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Cytomegalovirus Infections/*complications
Leukemia, Myeloid/*therapy
Polyradiculopathy/*virology
Acute Disease ; Antigens, CD34/metabolism ; Cytomegalovirus Infections/pathology ; Fatal Outcome ; Haploidy ; Hematopoietic Stem Cells/metabolism ; Humans ; Male ; Middle Aged ; Polyradiculopathy/pathology
Czasopismo naukowe
    Wyświetlanie 1-16 z 16

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies